Advocacy intelligence hub — real-time data for patient organizations
Zorbtive: FDA approved
Treatment of short bowel syndrome in patients receiving specialized nutritional support
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Zorbtive
EMD Serono, Inc.
Patient Assistance Programs1
Blenoxane
Bristol-Myers Squibb Pharmaceutical Research Institute